Company
OXCan
Transforming Lung Disease with a Single Blood Draw
Also known as Oxford Cancer Analytics
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Oxford, Oxfordshire, United Kingdom
- Legal name
- Oxford Cancer Analytics
Claim, correct or request removal
Record updated 28 September 2026
About
To develop minimally invasive, scalable diagnostic approaches that support evidence-based decision-making across respiratory disease, beginning with COPD and extending to applications in lung cancer.
Funding snapshot
- Total raised
- $11MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $11M2025-01-09
Funding rounds
- Series A
- $11M2025-01-09, Company stated
Products
- Other
- blood tests for early cancer detection
Loading relationship preview